Qt Group Oyj (QTGPF)

Oncternal Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	91.53	64.86	33.6	8.82	17.37	22.05
Cash & Short-Term Investments	91.53	64.86	33.6	8.82	17.37	22.05
Cash Growth	126.85%	93.07%	281.11%	-49.26%	-21.19%	84.58%
Accounts Receivable	47.18	63.58	57.36	46.92	29.12	17.77
Other Receivables	16.64	15.92	10.47	10.86	14.01	7.08
Receivables	63.82	79.5	67.82	57.78	43.13	24.85
Other Current Assets	-	0.85	0.74	-	0.08	0.08
Total Current Assets	155.36	145.21	102.15	66.6	60.58	46.98
Property, Plant & Equipment	8.72	5.78	5.52	5.43	3.05	3.18
Goodwill	44.37	44.37	44.37	43.38	25.41	6.56
Other Intangible Assets	35.12	39.16	47.2	55.36	26.49	3.71
Long-Term Accounts Receivable	2.51	3.25	6.26	6.21	-	-
Long-Term Deferred Tax Assets	1.15	0.87	0.96	0.76	1.35	0.68
Other Long-Term Assets	0.11	0.13	0.05	0.36	0.34	0.31
Total Assets	247.33	238.76	206.51	178.1	117.22	61.42
Accounts Payable	2.32	2.28	2.25	2.58	2.17	1.57
Accrued Expenses	-	13.04	15.18	15.18	13.79	8.3
Short-Term Debt	-	-	-	-	15	-
Current Portion of Long-Term Debt	-	-	16.3	0.16	-	-
Current Portion of Leases	3.14	2.12	2.21	1.87	0.86	1.28
Other Current Liabilities	32.12	23.66	21.07	16.66	20.32	16.1
Total Current Liabilities	37.58	41.09	57.01	36.44	52.14	27.25
Long-Term Debt	-	-	-	24	-	-
Long-Term Leases	4.39	2.2	2	2.14	1.17	1.37
Long-Term Deferred Tax Liabilities	10.21	11.39	13.83	16.24	7.5	0.5
Other Long-Term Liabilities	5.45	5.66	11.33	12.57	4.84	2.42
Total Liabilities	57.63	60.33	84.16	91.38	65.65	31.54
Common Stock	0.5	0.5	0.5	0.5	0.5	0.5
Retained Earnings	145.42	132.96	76.83	41	32.74	7.52
Treasury Stock	-9.96	-9.96	-9.96	-9.96	-18.35	-7.28
Comprehensive Income & Other	53.74	54.93	54.98	55.19	36.68	29.15
Shareholders' Equity	189.7	178.43	122.35	86.73	51.57	29.88
Total Liabilities & Equity	247.33	238.76	206.51	178.1	117.22	61.42
Total Debt	7.53	4.32	20.51	28.16	17.03	2.66
Net Cash (Debt)	84.01	60.55	13.08	-19.34	0.35	19.39
Net Cash Growth	130.75%	362.81%	-	-	-98.22%	146.61%
Net Cash Per Share	3.30	2.38	0.51	-0.76	0.01	0.77
Filing Date Shares Outstanding	25.39	25.39	25.39	25.39	24.78	24.22
Total Common Shares Outstanding	25.39	25.39	25.39	25.32	24.78	24.22
Working Capital	117.78	104.12	45.15	30.16	8.44	19.73
Book Value Per Share	7.47	7.03	4.82	3.43	2.08	1.23
Tangible Book Value	110.22	94.9	30.79	-12.02	-0.33	19.61
Tangible Book Value Per Share	4.34	3.74	1.21	-0.47	-0.01	0.81
Machinery	-	5.5	4.36	3.68	2.78	2.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.